SCHEMBL10246737

SCHEMBL10246737

CCOC(=O)CCCOc1cc(/C(N)=N/O)cc(F)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP1A2 P05177 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
GAA P10253 3/20 0.36
TNF P01375 2/20 0.36
RAB9A P51151 2/20 0.36
BRD4 O60885 1/20 0.36
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
PTPN1 P18031 1/20 0.35
PDK2 Q15119 1/20 0.35
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL409895 1.00 L3MBTL1 (0.41) L3MBTL1TDP1CYP1A2MEN1KMT2A
SCHEMBL409894 1.00 L3MBTL1 (0.41) L3MBTL1TDP1CYP1A2MEN1KMT2A
SCHEMBL2805503 0.86 THRA (0.45) L3MBTL1TDP1CYP1A2MEN1KMT2A
SCHEMBL9968920 0.86 THRA (0.45) L3MBTL1TDP1CYP1A2MEN1KMT2A
SCHEMBL2804388 0.86 THRA (0.45) L3MBTL1TDP1CYP1A2MEN1KMT2A
SCHEMBL534785 0.84 TDP1 (0.39) L3MBTL1TDP1KMT2ARAB9ANPC1
SCHEMBL411214 0.78 CYP1A2 (0.41) CYP1A2MEN1KMT2APDE4APDE4B
SCHEMBL408974 0.75 TNF (0.39) CYP1A2MEN1KMT2APDE4APDE4B
SCHEMBL2771953 0.74 TDP1 (0.54) L3MBTL1TDP1KMT2AGAARAB9A
SCHEMBL9968921 0.74 TDP1 (0.54) L3MBTL1TDP1KMT2AGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414341-B1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2017-09-13 EP disclosed
US-8815919-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2014-08-26 US disclosed
US-20120022109-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-01-26 US disclosed
US-20120022109-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-01-26 US disclosed
WO-2010115751-A2 OXADIAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022109-A1 OXADIAZOLE DERIVATIVES OXA1L, HLA-DRB1, SSB L3MBTL1 4637/4885TDP1 1556/4885CYP1A2 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.